Applied Clinical Trials
Industry news focusing on the people and organizations who work in the clinical trials profession.
People
INC Research (Raleigh, NC) has appointed J. Michael Hamilton, MD, as senior medical director in its oncology practice.
MIchael Hamilton, MD
Douglas M. Fast, PhD, has joined Covance (Princeton, NJ) as Scientific Director Bioanalytical Services.
Douglas M. Fast, PhD
As CTASC's (Baltimore, MD) Senior Director of Biometrics Consulting, Jose Gallo, PhD, will lead its consulting team as it works with pharmaceutical and biotechnology companies to address biometric issues associated with clinical trial submissions.
Using her 13 years of experience, Melissa Cabral, who recently joined MediciGlobal's (King of Prussia, PA) Project Management Team, will guide client clinical teams in assessing the impact of study design on patient recruitment.
Jose Gallo, PhD
PharmaNet Development Group (Princeton, NJ) has expanded its Phase IV development team with the additions of Ron Weishaar as Executive Director of Observational Research, Mike Nelson as Executive Director of Health Economics and Outcomes Research, and Ken Ashman as Executive Director of European Operations.
Melissa Cabral
Anthony G. Busa, Jr., will use his 34 years of experience in management positions in his new role as Chief Executive Officer at CEDRA (Austin, TX).
Roch Doliveux has been appointed to the Governing Board of the Innovative Medicines Initiative (Brussels, Belgium), a public-private partnership between the EFPIA and the European Union.
Ricerca Biosciences (Concord, Ohio) has hired Michael E. Placke, PhD, as Senior Vice President and General Manager of its Concord, Ohio, facility.
Dave Tapolczay, PhD, has a new position as Non-Executive Chairman of Compandia (Nottingham, UK), a Biomarker detection company.
With more than 17 years of experience, David Heck will become D. Anderson & Company's (Dallas, TX) Vice President of Business Development.
Virtify (Cambridge, MA) has hired several new members to join its team, including John Murgo as Executive Vice President and Chief Financial Officer, Jawahar Tembulkar as Vice President of Engineering, Matthew Slough as General Manager for Philippines Operations, Peter Norton as Director of Customer Support, Scott Venable as Director of Product Implementation, and Paul Tecca as Director, Product Management, SCM Solutions.
With more than 12 years of experience in the pharmaceutical industry in both the United States and Singapore, Ying Zhang has been appointed the Director of Business Development for Clearstone Central Laboratories (Beijing, China).
Alliances
Awards
Accelovance accepts the "Best Contract Research Organization" award for the second year in a row at the 2010 World Vaccine Congress, held in Chantilly, VA.
Company News
Mergers/Acquisitions
New Facilities
Synteract employees celebrate the contract research organization's 15th anniversary in a group photo outside company headquarters in Carlsbad, California.
Products
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Phase III Trial Data Show Subcutaneous Pembrolizumab as Noninferior to IV Keytruda
March 31st 2025Subcutaneous administration of pembrolizumab with chemotherapy demonstrated a nearly 50% reduction in patient chair and treatment room time while maintaining efficacy and safety endpoints compared to intravenous Keytruda.
Phase II ALPACA Trial Shows Lepodisiran Produces Significant, Sustained Lipoprotein(a) Reductions
March 31st 2025Eli Lilly’s lepodisiran, an investigational siRNA therapy, achieved significant and durable reductions in lipoprotein(a) levels, a major genetic risk factor for cardiovascular disease.